Insights

Pain management is crucial for infants on respiratory support to reduce complications. This review covers drug evidence and practical pain control strategies for neonates receiving ventilation.

Area of Science:

  • Neonatal care
  • Pediatric critical care
  • Pharmacology

Background:

  • Infants requiring respiratory assistance often experience pain from their condition or the ventilation process.
  • Effective pain management in neonates receiving respiratory support is essential for minimizing adverse outcomes and improving recovery.
  • Understanding pain mechanisms and appropriate interventions is vital in neonatal intensive care units.

Purpose of the Study:

  • To review the scientific evidence on analgesic and sedative drug use in neonates undergoing mechanical ventilation.
  • To provide practical recommendations for pain management strategies in this vulnerable patient population.
  • To enhance the quality of care for infants receiving respiratory support by addressing pain.

Main Methods:

  • Systematic review of existing scientific literature on pain management in ventilated neonates.
  • Analysis of pharmacological agents commonly used for pain and sedation during mechanical ventilation.
  • Synthesis of evidence regarding efficacy and safety of different pain control methods.

Main Results:

  • Specific drug classes and agents are identified as effective for managing pain and procedural discomfort in neonates on ventilators.
  • Evidence supports the use of certain sedatives and analgesics to reduce physiological stress and improve tolerance to ventilation.
  • Optimal dosing and monitoring strategies are discussed based on current research.

Conclusions:

  • Pharmacological interventions play a significant role in mitigating pain and improving outcomes for infants on respiratory support.
  • Evidence-based pain management protocols are necessary for optimizing neonatal respiratory care.
  • Further research may refine optimal drug choices and non-pharmacological adjuncts for neonatal pain management during ventilation.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...